3026

Q4 Earnings Highs And Lows: Palantir (NYSE:PLTR) Vs The Rest Of The Data Analytics Stocks


Radek Strnad /
2023/03/22 6:47 am EDT

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to other peers in the same sector. Today we are looking at Palantir (NYSE:PLTR), and the best and worst performers in the data analytics group.

Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the silo-ed data.

The 5 data analytics stocks we track reported a weak Q4; on average, revenues beat analyst consensus estimates by 3.05%, while on average next quarter revenue guidance was 0.72% under consensus. Investors abandoned cash burning companies since high interest rates will make it harder to raise capital and data analytics stocks have not been spared, with share prices down 11.3% since the previous earnings results, on average.

Palantir (NYSE:PLTR)

Started by Peter Thiel after seeing US defence agencies struggle in the aftermath of the 2001 terrorist attacks, Palantir (NYSE:PLTR) offers software as a service platform that helps government agencies and large enterprises use data to make better decisions.

Palantir reported revenues of $508.6 million, up 17.5% year on year, in line with analyst expectations. It was a weak quarter for the company, with underwhelming revenue guidance for the next quarter and the full year.

“With this result, Palantir is profitable. This is a significant moment for us and our supporters,” said Alex Karp, co-founder and chief executive officer of Palantir Technologies.

Palantir Total Revenue

Palantir delivered the weakest performance against analyst estimates and weakest full year guidance update of the whole group. The stock is up 10.6% since the results and currently trades at $8.4.

Is now the time to buy Palantir? Access our full analysis of the earnings results here, it's free.

Best Q4: Alteryx (NYSE:AYX)

Initially created as a way to organise census data for the government, Alteryx (NYSE:AYX) provides software that helps companies automate and analyse their internal data processes.

Alteryx reported revenues of $301.1 million, up 73.2% year on year, beating analyst expectations by 7.79%. It was a decent quarter for the company, with exceptional revenue growth but underwhelming guidance for the next year.

Alteryx Total Revenue

Alteryx pulled off the strongest analyst estimates beat, fastest revenue growth, and highest full year guidance raise among its peers. The company added 18 customers to a total of 8,358. The stock is down 3.26% since the results and currently trades at $58.13.

Is now the time to buy Alteryx? Access our full analysis of the earnings results here, it's free.

Slowest Q4: Health Catalyst (NASDAQ:HCAT)

Founded by healthcare professionals Tom Burton and Steve Barlow in 2008, Health Catalyst (NASDAQ:HCAT) provides data and analytics technology to healthcare organizations, enabling them to improve care and lower costs.

Health Catalyst reported revenues of $69.2 million, up 6.87% year on year, beating analyst expectations by 1.32%. It was a weak quarter for the company, with full year guidance missing analysts' expectations.

Health Catalyst had the slowest revenue growth in the group. The stock is down 15.3% since the results and currently trades at $11.84.

Read our full analysis of Health Catalyst's results here.

Amplitude (NASDAQ:AMPL)

Born out of a failed voice recognition startup by founder Spenser Skates, Amplitude (NASDAQ:AMPL) is data analytics software helping companies improve and optimize their digital products.

Amplitude reported revenues of $65.3 million, up 32% year on year, beating analyst expectations by 2.63%. It was a weak quarter for the company, with decelerating customer growth and full year guidance missing analysts' expectations.

The company added 81 customers to a total of 1,994. The stock is down 24.2% since the results and currently trades at $12.7.

Read our full, actionable report on Amplitude here, it's free.

Domo (NASDAQ:DOMO)

Founded by Josh James after selling his former business Omniture to Adobe, Domo (NASDAQ:DOMO) provides business intelligence software that allows managers to access and visualize critical business metrics in real-time, using their smartphones.

Domo reported revenues of $79.6 million, up 13.8% year on year, beating analyst expectations by 2.77%. It was a weak quarter for the company, with a full year guidance missing analysts' expectations.

The stock is down 24.5% since the results and currently trades at $12.44.

Read our full, actionable report on Domo here, it's free.

The author has no position in any of the stocks mentioned